t - 医索

找到约 9305 条结果

Balancing efficacy and quality of lifein hormone receptor-positivemetastatic breast cancer

医客学院 - 会议报告集

Associations of predictive biomarkers(MHC-I and MHC-ll) with clinical and molecularfeatures in a diverse preast cancer cohort

医客学院 - 会议报告集

Association of MammaPrint index and 3-yearoutcome of patients in the FLEX Registry trial withHR HER2-early-stage breast cancer treated withchemotherapy with or without anthracycline

医客学院 - 会议报告集

ACE-Breast-02 a pivotal phase lllll trial of ARX788, anovel anti-HER2 ADC, vs lapatinib plus capecitabine forHER2 advanced breast cancer

医客学院 - 会议报告集

Abstract LBA509Rates of pathologic complete response(pCR)after neoadjuvant datopotomab deruxtecan(Dato-DXd) Results from the l-SPY 2.2trial

医客学院 - 会议报告集

A-BRAVE Trial

医客学院 - 会议报告集

Abemaciclib plus fulvestrant vs fulvestrant alone for HR HER2-advanced breast cancer following progression onprior CDK46 inhibitor plus endocrine therapy Primaryoutcome of the Phase 3 postMONARCH

医客学院 - 会议报告集

A Randomized, Multicenter, Open-label, Phase lll Trial ComparingAnthracyclines Followed by Taxane Versus Anthracyclines Followedby Taxane Plus Carboplatin as (Neo) Adjuvant Therapy in Patientswith

医客学院 - 会议报告集

slides-The_impact_of_adjuvant_endocrine_therapy_AET_omiss

医客学院 - 会议报告集

slides-Rates_of_pathologic_complete_response_pCRafter_neo

医客学院 - 会议报告集

今日实时热搜